<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37131482</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1177-889X</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Patient preference and adherence</Title><ISOAbbreviation>Patient Prefer Adherence</ISOAbbreviation></Journal><ArticleTitle>Validation of the Slovakian Version of the "Post&#x2011;acute (Long) COVID&#x2011;19 Quality of Life Instrument" and Pilot Study.</ArticleTitle><Pagination><StartPage>1137</StartPage><EndPage>1142</EndPage><MedlinePgn>1137-1142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/PPA.S404377</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The aim of our study was to validate a Slovakian translation of the PAC&#x2011;19QoL instrument among Slovakian patients with post COVID-19 syndrome.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">The PAC-19QoL instrument was translated into the Slovakian language and administrated to patients with post COVID-19 syndrome. Cronbach's alpha coefficient was used to analyse the internal consistency of the instrument. Construction validity was evaluated by using Pearson's correlation coefficient and Spearman's rank correlation. Scores of patients and controls were compared using Mann-Whitney <i>U</i>-test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Forty-five asymptomatic and forty-one symptomatic participants were included. Forty-one patients with post COVID-19 syndrome completed the PAC-19QoL and EQ-5D-5L questionnaires. PAC-19QoL domain scores were significantly different between symptomatic and asymptomatic participants. All items achieved a Cronbach alpha greater than 0.7. There was a significant correlation between all domains on the test (p &lt; 0.001), with the highest correlation of Total (r = 0.994) and Domain 1 (r = 0.991). Spearman's rank correlation analysis confirmed that the instrument items correlated with the objective PAC-19QoL examination findings.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The Slovakian version of the instrument is valid, reliable and can be a suitable tool for research and daily clinical practice among patients with post COVID-19 syndrome.</AbstractText><CopyrightInformation>&#xa9; 2023 Ulbrichtova et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ulbrichtova</LastName><ForeName>Romana</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2099-7744</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, 036 01, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vysehradsky</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, 036 01, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bencova</LastName><ForeName>Alica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Outpatient Clinic of Pneumology, Senium Medica, Martin, 036 01, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatarkova</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, 036 01, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osina</LastName><ForeName>Oto</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Clinic of Occupational Medicine and Toxicology, Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, 036 59, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svihrova</LastName><ForeName>Viera</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2593-0410</Identifier><AffiliationInfo><Affiliation>Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, 036 01, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hudeckova</LastName><ForeName>Henrieta</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Public Health, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, 036 01, Slovakia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Patient Prefer Adherence</MedlineTA><NlmUniqueID>101475748</NlmUniqueID><ISSNLinking>1177-889X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EQ-5D-5L</Keyword><Keyword MajorTopicYN="N">PAC-19QoL</Keyword><Keyword MajorTopicYN="N">post COVID</Keyword><Keyword MajorTopicYN="N">quality of live</Keyword><Keyword MajorTopicYN="N">validation</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>1</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37131482</ArticleId><ArticleId IdType="pmc">PMC10149059</ArticleId><ArticleId IdType="doi">10.2147/PPA.S404377</ArticleId><ArticleId IdType="pii">404377</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Available from: https://COVID19.who.int/. Accessed December
13, 2022.</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed November
12, 2022.</Citation></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2013;754. doi:10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159&#x2013;167. doi:10.1093/fampra/cmab076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G, Monaghan A, Xue F, Duggan E, Romero-Ortu&#xf1;o R. Comprehensive clinical characterisation of brain fog in adults reporting long COVID symptoms. J Clin Med. 2022;11(12):3440. doi:10.3390/jcm11123440</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11123440</ArticleId><ArticleId IdType="pmc">PMC9224578</ArticleId><ArticleId IdType="pubmed">35743516</ArticleId></ArticleIdList></Reference><Reference><Citation>EUROQOL. EQ-5D. Available from: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/. Accessed November
1, 2022.</Citation></Reference><Reference><Citation>Jandhyala R. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument. Health Qual Life Outcomes. 2021;19(1):229. doi:10.1186/s12955-021-01862-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01862-1</ArticleId><ArticleId IdType="pmc">PMC8477362</ArticleId><ArticleId IdType="pubmed">34583690</ArticleId></ArticleIdList></Reference><Reference><Citation>Eremenco S, Pease S, Mann S, Berry P. PRO consortium&#x2019;s process subcommittee. patient-reported outcome (PRO) consortium translation process: consensus development of updated best practices. J Patient Rep Outcomes. 2017;2(1):12. doi:10.1186/s41687-018-0037-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-018-0037-6</ArticleId><ArticleId IdType="pmc">PMC5934912</ArticleId><ArticleId IdType="pubmed">29757299</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Group ftGAC-P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. Health-related quality of life and its associated factors in COVID-19 patients. Osong Public Health Res Perspect. 2020;11(5):296&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577388</ArticleId><ArticleId IdType="pubmed">33117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent A, Dudoignon E, Ressaire Q, D&#xe9;pret F, Plaud B. Three-month quality of life in survivors of ARDS due to COVID-19: a preliminary report from a French academic centre. Anaesth Crit Care Pain Med. 2020;39(6):740&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547571</ArticleId><ArticleId IdType="pubmed">33049394</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611.e9&#x2013;611.e16. doi:10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al. Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. 2021;46(6):428&#x2013;436. doi:10.30476/ijms.2021.92080.2326</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022;94(1):253&#x2013;262. doi:10.1002/jmv.27309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>